Bone age is the best predictor of growth response to recombinant human growth hormone in Turner’s syndrome

BACKGROUND AND OBJECTIVES: Recombinant human growth hormone (rhGH) is approved for use in children with Turner’s syndrome (TS) in most industrialized countries and is recommended in the recently issued guidelines. We determined the growth responses of girls who are treated with rhGH for TS, with an...

Descripción completa

Detalles Bibliográficos
Autores principales: Ismail, Nagwa Abdallah, Eldin Metwaly, Nermeen Salah, El-Moguy, Fatma Ahmed, Hafez, Mona Hassan, Abd El Dayem, Soha M., Farid, Tarek Mohamed
Formato: Texto
Lenguaje:English
Publicado: Medknow Publications 2010
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3009421/
https://www.ncbi.nlm.nih.gov/pubmed/21206698
http://dx.doi.org/10.4103/0971-6866.73400

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3009421/
https://www.ncbi.nlm.nih.gov/pubmed/21206698
http://dx.doi.org/10.4103/0971-6866.73400

Ejemplares similares